skip to Main Content
All Sources
All Years


New drug may improve liver cancer therapy

Researchers from many international institutions have teamed up to design a more effective drug for liver cancer therapy. Their compound may help improve survival rates and reduce adverse effects.


Viral hepatitis burden in Europe

The HEPAHEALTH Project Report, produced by the European Association for the Study of the Liver (EASL), is the second overview commissioned by EASL on the burden of liver disease in Europe. The report encompasses…

Back To Top